Equities
  • Price (MXN)302.55
  • Today's Change0.00 / 0.00%
  • Shares traded8.45k
  • 1 Year change--
  • Beta1.5830
Data delayed at least 20 minutes, as of Jun 13 2025 12:30 BST.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

On Friday, Telix Pharmaceuticals Ltd (TLX1N:MEX) closed at 302.55, 0.00% below its 52-week high of 302.55, set on Jun 13, 2025.
52-week range
302.55Jun 13 2025302.55Jun 13 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open--
High302.55
Low302.55
Bid--
Offer--
Previous close302.55
Average volume--
Shares outstanding338.78m
Free float252.44m
P/E (TTM)206.25
Market cap2.97bn AUD
EPS (TTM)0.0425
AUD
Data delayed at least 20 minutes, as of Jun 13 2025 12:30 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.